Placeholder

R&D: The New Paradigm

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Large and small biopharma companies are seeking to increase the efficiency and productivity of their R&D functions. They are collaborating with nontraditional partners, gathering insights from observational studies, and leveraging analytics to increase throughput of the clinical development process.
Our experts say innovation in R&D is going beyond the science to tools, processes, technologies, and the operating models that result in higher productivity, global collaboration, and better decision-making throughout the R&D cycle. The emergence of new forms of collaboration and open innovation models will be an important part of improving the efficiency of R&D through greater standardization and reduced…

Sidebar:
New Models for Cancer
Pediatrics Regulations Updated
New Science Brings New Targets
A Holistic Open Learning Network ­Approach to R&D
Top 20 Most Valuable R&D Projects

 

FEEDBACK